These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 38290972)

  • 21. FOXM1 plays a role in autophagy by transcriptionally regulating Beclin-1 and LC3 genes in human triple-negative breast cancer cells.
    Hamurcu Z; Delibaşı N; Nalbantoglu U; Sener EF; Nurdinov N; Tascı B; Taheri S; Özkul Y; Donmez-Altuntas H; Canatan H; Ozpolat B
    J Mol Med (Berl); 2019 Apr; 97(4):491-508. PubMed ID: 30729279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LT-IIc, A Bacterial Type II Heat-Labile Enterotoxin, Induces Specific Lethality in Triple Negative Breast Cancer Cells by Modulation of Autophagy and Induction of Apoptosis and Necroptosis.
    Masso-Welch P; Girald Berlingeri S; King-Lyons ND; Mandell L; Hu J; Greene CJ; Federowicz M; Cao P; Connell TD; Heakal Y
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30587795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activating Transcription Factor 4 Modulates TGFβ-Induced Aggressiveness in Triple-Negative Breast Cancer via SMAD2/3/4 and mTORC2 Signaling.
    González-González A; Muñoz-Muela E; Marchal JA; Cara FE; Molina MP; Cruz-Lozano M; Jiménez G; Verma A; Ramírez A; Qian W; Chen W; Kozielski AJ; Elemento O; Martín-Salvago MD; Luque RJ; Rosa-Garrido C; Landeira D; Quintana-Romero M; Rosato RR; García MA; Ramirez-Tortosa CL; Kim H; Rodriguez-Aguayo C; Lopez-Berestein G; Sood AK; Lorente JA; Sánchez-Rovira P; Chang JC; Granados-Principal S
    Clin Cancer Res; 2018 Nov; 24(22):5697-5709. PubMed ID: 30012564
    [No Abstract]   [Full Text] [Related]  

  • 24. Patient-derived xenografts of triple-negative breast cancer reproduce molecular features of patient tumors and respond to mTOR inhibition.
    Zhang H; Cohen AL; Krishnakumar S; Wapnir IL; Veeriah S; Deng G; Coram MA; Piskun CM; Longacre TA; Herrler M; Frimannsson DO; Telli ML; Dirbas FM; Matin AC; Dairkee SH; Larijani B; Glinsky GV; Bild AH; Jeffrey SS
    Breast Cancer Res; 2014 Apr; 16(2):R36. PubMed ID: 24708766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of the novel histone deacetylase inhibitor YCW1 and radiation induces autophagic cell death through the downregulation of BNIP3 in triple-negative breast cancer cells in vitro and in an orthotopic mouse model.
    Chiu HW; Yeh YL; Wang YC; Huang WJ; Ho SY; Lin P; Wang YJ
    Mol Cancer; 2016 Jun; 15(1):46. PubMed ID: 27286975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TRIM21-regulated Annexin A2 plasma membrane trafficking facilitates osteosarcoma cell differentiation through the TFEB-mediated autophagy.
    Zhang HT; Zeng Q; Wu B; Lu J; Tong KL; Lin J; Liu QY; Xu L; Yang J; Liu X; Liu W; Zhang YF; Lian Q; Liu L; Gao X
    Cell Death Dis; 2021 Jan; 12(1):21. PubMed ID: 33414451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphorylation of EIF2S1 (eukaryotic translation initiation factor 2 subunit alpha) is indispensable for nuclear translocation of TFEB and TFE3 during ER stress.
    Dang TT; Kim MJ; Lee YY; Le HT; Kim KH; Nam S; Hyun SH; Kim HL; Chung SW; Chung HT; Jho EH; Yoshida H; Kim K; Park CY; Lee MS; Back SH
    Autophagy; 2023 Jul; 19(7):2111-2142. PubMed ID: 36719671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activated kinase screening identifies the
    Leonardi M; Perna E; Tronnolone S; Colecchia D; Chiariello M
    Autophagy; 2019 Feb; 15(2):312-326. PubMed ID: 30289335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. OSW-1 induces apoptosis and cyto-protective autophagy, and synergizes with chemotherapy on triple negative breast cancer metastasis.
    Wu M; Huang Q; Liao M; Wu X; Xi H; Ma H; Li S; Zhang Y; Xia Y
    Cell Oncol (Dordr); 2022 Dec; 45(6):1255-1275. PubMed ID: 36155886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Annexin A2 depletion delays EGFR endocytic trafficking via cofilin activation and enhances EGFR signaling and metastasis formation.
    de Graauw M; Cao L; Winkel L; van Miltenburg MH; le Dévédec SE; Klop M; Yan K; Pont C; Rogkoti VM; Tijsma A; Chaudhuri A; Lalai R; Price L; Verbeek F; van de Water B
    Oncogene; 2014 May; 33(20):2610-9. PubMed ID: 23792445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AKT inhibition-mediated dephosphorylation of TFE3 promotes overactive autophagy independent of MTORC1 in cadmium-exposed bone mesenchymal stem cells.
    Pi H; Li M; Zou L; Yang M; Deng P; Fan T; Liu M; Tian L; Tu M; Xie J; Chen M; Li H; Xi Y; Zhang L; He M; Lu Y; Chen C; Zhang T; Wang Z; Yu Z; Gao F; Zhou Z
    Autophagy; 2019 Apr; 15(4):565-582. PubMed ID: 30324847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A lysosome independent role for TFEB in activating DNA repair and inhibiting apoptosis in breast cancer cells.
    Slade L; Biswas D; Ihionu F; El Hiani Y; Kienesberger PC; Pulinilkunnil T
    Biochem J; 2020 Jan; 477(1):137-160. PubMed ID: 31820786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How autophagy controls the intestinal epithelial barrier.
    Foerster EG; Mukherjee T; Cabral-Fernandes L; Rocha JDB; Girardin SE; Philpott DJ
    Autophagy; 2022 Jan; 18(1):86-103. PubMed ID: 33906557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Annexin A2 plays a key role in protecting against cisplatin-induced AKI through β-catenin/TFEB pathway.
    Shen K; Miao J; Gao Q; Ling X; Liang Y; Zhou Q; Song Q; Luo Y; Wu Q; Shen W; Wang X; Li X; Liu Y; Zhou S; Tang Y; Zhou L
    Cell Death Discov; 2022 Oct; 8(1):430. PubMed ID: 36307397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual-target MDM2/MDMX inhibitor increases the sensitization of doxorubicin and inhibits migration and invasion abilities of triple-negative breast cancer cells through activation of TAB1/TAK1/p38 MAPK pathway.
    Fan Y; Li M; Ma K; Hu Y; Jing J; Shi Y; Li E; Dong D
    Cancer Biol Ther; 2019; 20(5):617-632. PubMed ID: 30462562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.
    Li M; Li AQ; Zhou SL; Lv H; Wei P; Yang WT
    J Exp Clin Cancer Res; 2020 May; 39(1):92. PubMed ID: 32448269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Significance of Annexin A2 Expression in Breast Cancer Patients.
    Gibbs LD; Mansheim K; Maji S; Nandy R; Lewis CM; Vishwanatha JK; Chaudhary P
    Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33374917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of Small Extracellular Vesicle-Derived Annexin A2 Protein and mRNA as a Potential Predictive Biomarker for Chemotherapy Responsiveness in Aggressive Triple-Negative Breast Cancer.
    Desai PP; Narra K; James JD; Jones HP; Tripathi AK; Vishwanatha JK
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. mTORC2/AKT/HSF1/HuR constitute a feed-forward loop regulating Rictor expression and tumor growth in glioblastoma.
    Holmes B; Benavides-Serrato A; Freeman RS; Landon KA; Bashir T; Nishimura RN; Gera J
    Oncogene; 2018 Feb; 37(6):732-743. PubMed ID: 29059166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flubendazole elicits anti-cancer effects via targeting EVA1A-modulated autophagy and apoptosis in Triple-negative Breast Cancer.
    Zhen Y; Zhao R; Wang M; Jiang X; Gao F; Fu L; Zhang L; Zhou XL
    Theranostics; 2020; 10(18):8080-8097. PubMed ID: 32724459
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.